September 24, 2026
BeBack moves forward: Built to cross and ready to re-enter

While many physicians have traditionally associated BeBack with re-entry in complex CTO procedures only, growing clinical experience is broadening the discussion around its role. Today, more physicians are recognizing the BeBack catheter as a versatile tool for both crossing and re-entry.
Rather than being reserved for challenging bailout situations, BeBack is gaining attention as a device that can support both intraluminal crossing and targeted re-entry, giving physicians more options throughout the revascularization. This shift in perception was evident in discussions with physicians during CIRSE 2026, where the BeBack emerged as one of the most talked-about products in Bentley's peripheral product offering.
Recent expert commentary published in and has highlighted the importance of early escalation in complex CTO cases and the value of maintaining control over the crossing strategy from the outset. The ability to switch between crossing techniques with a single device while preserving downstream treatment options is increasingly being recognized as an advantage in everyday practice.

Consultant Interventional Radiologist at Somerset NHS Foundation Trust
This evolving clinical role is accompanied by an important production update:
BeBack is now manufactured in Hechingen, Germany.
The production transfer reflects Bentley's continued commitment to strengthening manufacturing capabilities in Germany. As the company expands its production infrastructure and invests in local expertise, BeBack will be manufactured in the heart of Bentley's operations, reinforcing quality standards, supply reliability and the company's long-term commitment to German medical device manufacturing.
The move also further strengthens the "Made in Germany" positioning of BeBack, reflecting Bentley's belief in local manufacturing, engineering excellence and sustainable growth through investment in regional capabilities and jobs.
Supporting this next chapter, BeBack recently received the MDR certification, reinforcing Bentley's ongoing commitment to quality, regulatory compliance, and long-term product availability for physicians treating peripheral CTO’s. In addition, the catheter is now packed with a more compact outer box design that uses less material while maintaining the same level of quality and usability.
As PAD interventions continue to evolve, the discussion around BeBack is evolving as well. More and more, the device is being considered not only as a re-entry solution, but as a versatile crossing and re-entry tool designed to help physicians approach complex CTO procedures with greater control, flexibility and confidence.
Taken together, these developments mark an important new chapter in the ongoing evolution for the BeBack catheter.